Cryoport Reports 56% Revenue Growth for Fiscal Year Ended December 31, 2017

Go back to Cryoport Reports 56% Revenue Growth for Fiscal Year Ended December 31, 2017

CryoPort (CYRX) PT Raised to $11 at Needham & Company

March 7, 2018 7:53 AM EST

Needham & Company raised its price target on CryoPort (NASDAQ: CYRX) to $11.00 (from $10.00) while maintaining a Buy rating.

Analyst Sean Hannan commented, "After the close CYRX reported healthy results further demonstrating continued execution capturing new trials (up an impressive 19 q/ q) and operational discipline... More